Unknown

Dataset Information

Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19.


ABSTRACT:

Background

The pandemic of coronavirus disease 2019 (COVID-19) has emerged as a relevant threat for humans worldwide. Abnormality in liver function tests (LFTs) has been commonly observed in patients with COVID-19, but there is controversy on its clinical significance. The aim of this study was to assess the prevalence, the characteristics and the clinical impact of abnormal LFTs in hospitalized, non-critically ill patients with COVID-19.

Methods

In this multicentre, retrospective study, we collected data about 565 inpatients with COVID-19. Data on LFTs were collected at admission and every 7 ± 2 days during the hospitalization. The primary outcome was a composite endpoint of death or transfer to intensive care unit (ICU).

Results

Upon admission 329 patients (58%) had

SUBMITTER: Piano S 

PROVIDER: S-EPMC7307119 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature